Have a personal or library account? Click to login

Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital

Open Access
|Jun 2014

References

  1. 1. Jaenson TGT, Jaenson DGE, Eisen L, Petersson E, Lindgren E. Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit Vectors. 2012;10:5-8. DOI: 10.1186/1756-3305-5-8.10.1186/1756-3305-5-8
  2. 2. Berglund J, Eitrem R, Ornstein K. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-27. DOI: 10.1056/ NEJM19951116333200410.1056/NEJM199511163332004
  3. 3. Strle F. Lyme borreliosis in Slovenia. Zentralbl Bakteriol. 1999;289(5-7):643-52. DOI: 10.1016/S0934-8840(99)80023-110.1016/S0934-8840(99)80023-1
  4. 4. Zöldi V, Juhász A, Nagy C, Papp Z, Egyed L. Tickborne encephalitis and Lyme disease in Hungary: the epidemiological situation between 1998 and 2008. Vector Borne Zoonotic Dis. 2013 Apr;13(4):256-65. DOI: 10.1089/vbz.2011.090510.1089/vbz.2011.090523428090
  5. 5. Mukhacheva TA, Kovalev SY. Multilocus sequence analysis of Borrelia burgdorferi s.l. in Russia. Ticks Tick Borne Dis. 2013 Jun;4(4):275-9. DOI: 10.1016/j. ttbdis.2013.02.004
  6. 6. Coipan EC, Vladimirescu AF. Ixodes ricinus ticks (Acari: Ixodidae): vectors for Lyme disease spirochetes in Romania. Exp Appl Acarol. 2011;54(3):293-300. DOI: 10.1007/s10493-011-9438-410.1007/s10493-011-9438-421431930
  7. 7. Kiss T, Cadar D, Krupaci AF, Bordeanu A, Brudaşcă GF, Mihalca AD, et al. Serological reactivity to Borrelia burgdorferi sensu lato in dogs and horses from distinct areas in Romania. Vector Borne Zoonotic Dis. 2011;11(9):1259-62. DOI: 10.1089/vbz.2010.025410.1089/vbz.2010.025421612524
  8. 8. Hristea A, Hristescu S, Ciufecu C, Vasile A. Seroprevalence of Borrelia burgdorferi in Romania. Eur J Epidemiol. 2001;17(9):891-6. DOI: 10.1023/A:101560072990010.1023/A:1015600729900
  9. 9. Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, et al. European Union Concerted Action on Risk Assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr; 1996;108(23):741-7.
  10. 10. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2006;43(9):1089-134. DOI: 10.1086/50866710.1086/50866717029130
  11. 11. Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V. Improvement of Lyme Borreliosis Serodiagnosis by a Newly Developed Recombinant Immunoglobulin G (IgG) and IgM Line Immunoblot Assay and Addition of VlsE and DbpA Homologues Gereon Goettner. J Clin Microbiol. 2005;43(8):3602-9. DOI: 10.1128/JCM.43.8.3602-3609.200510.1128/JCM.43.8.3602-3609.2005123398416081885
  12. 12. Rosner B. Fundamentals of Biostatistics, 7th Edition. Duxbury Press, 2010.
  13. 13. Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitology. 2004;129 Suppl: S191-220. DOI: 10.1017/S003118200300469410.1017/S0031182003004694
  14. 14. Tijsse-Klasen E, Pandak N, Hengeveld P, Takumi K, Koopmans MPG, Sprong H. Ability to cause erythema migrans differs between Borrelia burgdorferi sensu lato isolates. Parasit Vectors. 2013;6:23. DOI: 10.1186/1756-3305-6-2310.1186/1756-3305-6-23359912623339549
  15. 15. Svihrova V, Hudeckova H, Jesenak M, Schwarzova K, Kostanova Z, Ciznar I. Lyme borreliosis--analysis of the trends in Slovakia1999-2008. Folia Microbiol. 2011;56(3):270-5. DOI: 10.1007/s12223-011-0036-y10.1007/s12223-011-0036-y21607749
  16. 16. Bartosik K, Lachowska-Kotowska P, Szymańska J, Pabis A, Buczek A. Lyme borreliosis in south-eastern Poland: relationships with environmental factors and medical attention standards. Ann Agric Environ Med. 2011;18(1):131-7.
  17. 17. Van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993 Oct;17(4):708-17. DOI: 10.1093/clinids/17.4.70810.1093/clinids/17.4.7087903558
  18. 18. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture- confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999;130(1):32-6. DOI: 10.7326/0003-4819-130-1-199901050-0000610.7326/0003-4819-130-1-199901050-000069890847
  19. 19. Richter D, Klug B, Spielman A, Matuschka FR. Adaptation of Diverse Lyme Disease Spirochetes in a Natural Rodent Reservoir Host. Infect Immun 2004;72(4):2442-4. DOI: 10.1128/IAI.72.4.2442-2444.200410.1128/IAI.72.4.2442-2444.200437519115039378
  20. 20. Strle F, Ružić-Sabljić E, Logar M, Maraspin V, Lotrič-Furlan S, Cimperman J, et al. Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis. 2011;11(9):1253-8 DOI: 10.1089/vbz.2010.023010.1089/vbz.2010.023021612533
  21. 21. Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin North Am. 2008;22(2):235-60. DOI: 10.1016/j.idc.2007.12.01210.1016/j.idc.2007.12.01218452799
  22. 22. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461-73. DOI: 10.1016/ S0140-6736(11)60103-7
  23. 23. Stupica D, Lusa L, Cerar T, Ružić-Sabljić E, Strle F. Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture. Vector Borne Zoonotic Dis. 2011;11(7):883-9. DOI: 10.1089/ vbz.2010.001810.1089/vbz.2010.001821083376
  24. 24. Glatz M, Golestani M, Kerl H, Müllegger RR. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Arch Dermatol. 2006;142(7):862-8. DOI: 10.1001/archderm.142.7.86210.1001/archderm.142.7.86216847202
  25. 25. Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, et al. Ceftriaxone compared with doxycicline for the treatment of acute disseminated Lyme disease. N Engl J Med. 1997;337(5):289-94. DOI: 10.1056/NEJM19970731337050110.1056/NEJM1997073133705019233865
  26. 26. Massarotti EM, Luger SW, Rahn DW, Messner RP, Wong JB, Johnson RC, et al. Treatment of early Lyme disease. Am J Med. 1992;92(4):396-403. DOI: 10.1016/0002-9343(92)90270-L10.1016/0002-9343(92)90270-L
  27. 27. Weber K, Wilske B, Preac-Mursic V, Thurmayr R. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection. 1993; 21(6):367-372. DOI: 10.1007/BF0172891510.1007/BF01728915
  28. 28. Nowakowski J, Nadelman RB, Sell R, McKenna D, Cavaliere LF, Holmgren D. et al. Longterm follow-up of patients with culture-confirmed Lyme disease. Am J Med. 2003;115(2):91-6. DOI: 10.1016/S0002-9343(03)00308-510.1016/S0002-9343(03)00308-5
  29. 29. Wormser, GP, Ramanathan, R, Nowakowski, J, McKenna, D, Holmgren D, Visintainer P, et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med.2003;138(9):697-704. DOI: 10.7326/0003-4819-138-9-200305060-0000510.7326/0003-4819-138-9-200305060-0000512729423
  30. 30. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 2001;33(6):780-5. DOI: 10.1086/32266910.1086/32266911512082
  31. 31. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B-cells. Science. 2002;298(5601):2199-202. DOI: 10.1126/science.107607110.1126/science.107607112481138
  32. 32. Aguero Rosenfeld ME, Nowakowski J, Bittker S, CooperD, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34(1):1-9.10.1128/jcm.34.1.1-9.19962287188748261
  33. 33. Mullegger RR, Glatz M. Is serological follow-up useful for patients with cutaneous Lyme borreliosis? Curr Probl Dermatol. 2009;37:178-82. DOI: 10.1159/000213075 10.1159/00021307519367102
DOI: https://doi.org/10.2478/rrlm-2014-0021 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 221 - 231
Submitted on: Dec 4, 2013
Accepted on: May 25, 2014
Published on: Jun 21, 2014
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2014 Mihaela Lupșe, Violeta Briciu, Mirela Flonta, Violeta Nastase, Nicolae Todor, Bart-Jan Kullberg, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.